Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Completely lack of ability in doing clinical trials. Don’t trust these management!
Damn it..bad management! A crab!
Nearly all management had been in this company for many many years.. seems dead wood already .. milking this company!
This company has been listed for more than 30 years! But nothing achieved, really!
I should have known this is crab as there is No financial institution holding! This management has milk from shareholders for 30+ years !
Wtf, E&Y declined the reappointment as auditors !!
Shorters are bastard earning nothing in shorting this kind of stock!!
Very bad… 99% holdings in hand of public!!!
Over 30 years company…Only 11 employees and very few financial institutional investors …very bad…
A crook..
No more oral COVID pill… a spam..
Instead of giving updates, company chooses to publish those old information which already published .. it is not alert at all! It just so amazing a company keeps on publishing old information not bothering how public would expect.
Further adjourning shareholders meeting. Klaus, don’t waste your time. It’s time to consider AEZS to buy back some share from the market. Or else AEZS is facing delisting..
Really pk..
Just a pump & dump.. really crab!
Damn…
The share consolidation did not get shareholders approval… going to be delisted or going to pink… AEZS has sufficient cash to buy back 100 million shares and still leaving plenty amount for R&D. Buy back shares also show management is confident on its current candidates! AEZS is very risky facing delisted! What have you voted on this?
Shorters keep shorting this stock in view of RS. Management is bad and this stock is crab!
Pedi test is just a test, not a drug.., not much value, right?!
Recent news on NMOSD is useless.. target patient population is talking about 10000-15000 patients only!
Recent news on proved concept on OMOSD is only for 10000-15000 patients. Candidates for just so small population are of little market value however it said unmet needs. And COVID is now gone! Story on oral COVID pill also of little value! Very bad management indeed!
If this goes pink or delisted, I would be in big trouble…
When will AEZS has FDA news on candidates?
Damn these shortest! And crab management!
Crab!
Horrible stock..horrible management..invalid phone no published in FB..
It is all pk!
Maybe AEZS was a real company but not already. It is terrible a real company with its company phone number being INVALID!
A company with invalid phone number, and investors relation contact no just voice recording… no idea whether this is a real company or not.. very terrible.
The FB information for AEZS phone no +498334758247 is an invalid phone!! Really a scam!! https://www.facebook.com/aezsinc/?ref=page_internal
How many shares owned by financial institutions? Is it just 2%?? If yes, majority is public shareholders - owning 120 million shares ..? RS is damaging public shareholders..
Wtf….not able to sell in the market now.. don’t know why..
If so, why there are no management buy shares from the market now..?
Horrible!
Totally agreed, this is useless cow..
Any more value for pills as there are already two oral COVID pills in the market?
Crap!
Because of weak & crap management, that’s why price is easily manipulated !
Oral COVID pill opportunity is gone. The market has already two oral COVID pill.
No more news for more than 3 quarters from now… high risk being delisted …very bad scammm